Fingerprint
Dive into the research topics of 'Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically